Related Experiment Video
Updated: Mar 3, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma
Yohei Kitamura1, Hikaru Sasaki2, Kazunari Yoshida2
1Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. ykita@sc4.so-net.ne.jp.
Abstract:
Chordomas and chondrosarcomas are two major malignant bone neoplasms located at the skull base. These tumors are rarely metastatic, but can be locally invasive and resistant to conventional chemotherapies and radiotherapies. Accordingly, therapeutic approaches for the treatment of these tumors can be difficult. Additionally, their location at the skull base makes them problematic. Although accurate diagnosis of these tumors is important because of their distinct prognoses, distinguishing between these tumor types is difficult due to overlapping radiological and histopathological findings. However, recent accumulation of molecular and genetic studies, including extracranial location analysis, has provided us clues for accurate diagnosis. In this report, we review the genetic aberrations and molecular biology of these two tumor types. Among the abundant genetic features of these tumors, brachyury immunohistochemistry and direct sequencing of IDH1/2 are simple and useful techniques that can be used to distinguish between these tumors. Although it is still unclear why these tumors, which have such distinct genetic backgrounds, show similar histopathological findings, comparison of their genetic backgrounds could provide essential information.
Insights
Chordomas and chondrosarcomas are challenging skull base bone tumors. Molecular and genetic analysis, including brachyury immunohistochemistry and IDH1/2 sequencing, aids in distinguishing these tumors with distinct prognoses.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Chordomas and chondrosarcomas are rare malignant bone neoplasms of the skull base.
- These tumors are locally invasive, resistant to conventional therapies, and difficult to diagnose due to overlapping features.
Purpose of the Study:
- To review the genetic aberrations and molecular biology of chordomas and chondrosarcomas.
- To highlight diagnostic techniques for differentiating these challenging skull base tumors.
Main Methods:
- Review of recent molecular and genetic studies.
- Analysis of genetic features including brachyury immunohistochemistry and IDH1/2 sequencing.
Main Results:
- Chordomas and chondrosarcomas exhibit distinct genetic backgrounds.
- Brachyury immunohistochemistry and IDH1/2 sequencing are effective in distinguishing between these tumor types.
Conclusions:
- Accurate diagnosis of skull base chordomas and chondrosarcomas is crucial due to differing prognoses.
- Molecular and genetic insights are essential for differentiating these neoplasms despite similar histopathological findings.
Related Concept Videos
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

